List of quality statements
Statement 1 People with suspected persistent synovitis affecting the small joints of the hands or feet, or more than one joint, are referred to a rheumatology service within 3 working days of presentation.
Statement 2 People with suspected persistent synovitis are assessed in a rheumatology service within 3 weeks of referral.
Statement 3 People with newly diagnosed rheumatoid arthritis are offered conventional disease-modifying anti-rheumatic drug (cDMARD) monotherapy within 3 months of onset of persistent symptoms.
Statement 4 People with rheumatoid arthritis are offered educational and self-management activities within 1 month of diagnosis.
Statement 5 People who have active rheumatoid arthritis have their C-reactive protein (CRP) and disease activity measured monthly in specialist care until they are in remission or have low disease activity.
Statement 6 People with rheumatoid arthritis and disease flares or possible drug related side effects receive advice within 1 working day of contacting the rheumatology service.
Statement 7 People with rheumatoid arthritis have a comprehensive annual review that is coordinated by the rheumatology service.
Other quality standards that should also be considered when choosing, commissioning or providing a high-quality rheumatoid arthritis service are listed in related quality standards.